Exicure, Inc. (XCUR)
$1.21+5.22%Close
SELLRECOVERY · day 1
Key stats
Short interest · FINRA settlement 2026-09-30
- Market cap
- $8M
- Beta
- 3.63
- P/E (TTM)
- -0.92
- Short % float
- 2.10%
- Days to cover
- 2.0
- SI change
- -46.9%
- 1W
- +18.63%
- 1M
- -7.63%
- vs SPY 1W
- +19.61%
- vs SPY 1M
- -9.50%
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
Company news
FAQ
- What is LOPJLB’s current signal on XCUR?
- LOPJLB’s latest quantitative signal on Exicure, Inc. (XCUR) is SELL in a RECOVERY regime. Signals are updated daily.
- What market regime is XCUR in?
- Exicure, Inc. (XCUR) is currently classified in the RECOVERY HMM market regime on LOPJLB.
- What does Exicure, Inc. (XCUR) do?
- Exicure, Inc. does not have significant operations. Previously, it focused on developing nucleic acid therapies targeting ribonucleic acid against validated targets. The company has a co-development agreement with Adbiotech Co., Ltd. to explore combination therapies based on Burixafor (GPC-100) across multiple therapeutic areas. Exicure, Inc. was founded in 2011 and is headquartered in Redwood …